Congress Should Act to Fund Medical-Legal Partnerships
We encourage Congress to pass recently introduced legislation that allocates funding to the development of Medical-Legal Partnerships.

FDA’s approval of aducanumab may run against the bioethical principles of beneficence and non-maleficence.
Patients are understandably desperate, but their needs are best served by following the science, rather than lowering the standards for drugs.
Family caregivers hold a critical role in the health care system and the economy, but do not receive adequate support and recognition.